Compare Stocks: PJP, LABU, XPH, and BBH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBH VanEck Biotech ETF	$229.64 +0.4%	$220.13	$160.91 ▼ $244.35	$463.33M	0.7	12,641 shs	2,842 shs
LABU Direxion Daily S&P Biotech Bull 3X ETF	$261.30 -1.8%	$282.15	$74.95 ▼ $341.93	$567.02M	2.44	562,529 shs	226,840 shs
PJP Invesco Pharmaceuticals ETF	$124.09 -0.5%	$124.18	$90.01 ▼ $131.68	$476.51M	0.45	35,987 shs	26,403 shs
XPH SPDR S&P Pharmaceuticals ETF	$67.51 -0.7%	$69.83	$45.80 ▼ $74.35	$486.07M	0.59	97,618 shs	425,406 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBH VanEck Biotech ETF	+0.44%	-4.76%	+4.26%	+22.44%	+38.47%
LABU Direxion Daily S&P Biotech Bull 3X ETF	-1.77%	-13.92%	-8.88%	+46.29%	+233.29%
PJP Invesco Pharmaceuticals ETF	-0.52%	-3.92%	-0.73%	+8.99%	+33.60%
XPH SPDR S&P Pharmaceuticals ETF	-0.74%	-4.82%	-3.29%	+12.01%	+42.70%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBH VanEck Biotech ETF	$229.64 +0.4%	$220.13	$160.91 ▼ $244.35	$463.33M	0.7	12,641 shs	2,842 shs
LABU Direxion Daily S&P Biotech Bull 3X ETF	$261.30 -1.8%	$282.15	$74.95 ▼ $341.93	$567.02M	2.44	562,529 shs	226,840 shs
PJP Invesco Pharmaceuticals ETF	$124.09 -0.5%	$124.18	$90.01 ▼ $131.68	$476.51M	0.45	35,987 shs	26,403 shs
XPH SPDR S&P Pharmaceuticals ETF	$67.51 -0.7%	$69.83	$45.80 ▼ $74.35	$486.07M	0.59	97,618 shs	425,406 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBH VanEck Biotech ETF	+0.44%	-4.76%	+4.26%	+22.44%	+38.47%
LABU Direxion Daily S&P Biotech Bull 3X ETF	-1.77%	-13.92%	-8.88%	+46.29%	+233.29%
PJP Invesco Pharmaceuticals ETF	-0.52%	-3.92%	-0.73%	+8.99%	+33.60%
XPH SPDR S&P Pharmaceuticals ETF	-0.74%	-4.82%	-3.29%	+12.01%	+42.70%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBH VanEck Biotech ETF	2.67	Moderate Buy	$229.64	N/A
LABU Direxion Daily S&P Biotech Bull 3X ETF	2.65	Moderate Buy	$261.30	N/A
PJP Invesco Pharmaceuticals ETF	2.63	Moderate Buy	$124.09	N/A
XPH SPDR S&P Pharmaceuticals ETF	2.68	Moderate Buy	$67.51	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBH VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A	N/A
LABU Direxion Daily S&P Biotech Bull 3X ETF	N/A	N/A	N/A	N/A	N/A	N/A
PJP Invesco Pharmaceuticals ETF	N/A	N/A	N/A	N/A	N/A	N/A
XPH SPDR S&P Pharmaceuticals ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBH VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LABU Direxion Daily S&P Biotech Bull 3X ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PJP Invesco Pharmaceuticals ETF	N/A	N/A	15.59	N/A	N/A	N/A	N/A	N/A	N/A
XPH SPDR S&P Pharmaceuticals ETF	N/A	N/A	14.28	N/A	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBH VanEck Biotech ETF	N/A	N/A	N/A	N/A	N/A
LABU Direxion Daily S&P Biotech Bull 3X ETF	$1.01	0.39%	N/A	N/A	N/A
PJP Invesco Pharmaceuticals ETF	$1.06	0.85%	N/A	N/A	N/A
XPH SPDR S&P Pharmaceuticals ETF	$0.33	0.49%	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBH VanEck Biotech ETF	32.05%
LABU Direxion Daily S&P Biotech Bull 3X ETF	N/A
PJP Invesco Pharmaceuticals ETF	N/A
XPH SPDR S&P Pharmaceuticals ETF	N/A

Insider Ownership

Company	Insider Ownership
BBH VanEck Biotech ETF	N/A
LABU Direxion Daily S&P Biotech Bull 3X ETF	N/A
PJP Invesco Pharmaceuticals ETF	N/A
XPH SPDR S&P Pharmaceuticals ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBH VanEck Biotech ETF	N/A	2.03 million	N/A	Optionable
LABU Direxion Daily S&P Biotech Bull 3X ETF	N/A	2.17 million	N/A	Not Optionable
PJP Invesco Pharmaceuticals ETF	N/A	3.84 million	N/A	Not Optionable
XPH SPDR S&P Pharmaceuticals ETF	N/A	7.20 million	N/A	Not Optionable

PJP, LABU, XPH, and BBH Headlines

Recent News About These Companies

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

September 11 at 9:29 PM | fool.com

Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPH

September 10 at 5:15 PM | finance.yahoo.com

XPH: Dividendenhistorie, Rendite und Ex-Dividenden-Tag

August 23, 2026 | de.investing.com

XPH vs PJP: Which Pharma ETF Offers Better Value

August 17, 2026 | fool.com

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

August 7, 2026 | zacks.com

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

August 6, 2026 | zacks.com

State Street SPDR S&P Pharmaceuticals ETF (XPH)

July 31, 2026 | finance.yahoo.com

Pharmaceuticals still a defensive play amid AI and geopolitical anxieties – analyst

July 21, 2026 | seekingalpha.com

Healthcare Rules State Street's Top 5 ETFs in Past Month

July 17, 2026 | etftrends.comE

Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?

July 8, 2026 | aol.comA

SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0590

June 22, 2026 | msn.com

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

June 5, 2026 | zacks.com

US FDA to review AI-based tool to predict drug-related liver damage

June 3, 2026 | reuters.com

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

June 3, 2026 | zacks.com

Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?

May 19, 2026 | 247wallst.com

Trump to announce discount drug pricing expansion, White House official says

May 18, 2026 | reuters.com

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

April 3, 2026 | zacks.com

Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?

March 30, 2026 | zacks.com

SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.0610

March 23, 2026 | msn.com

US and China clash over fentanyl and tariffs at global drugs meeting

March 9, 2026 | reuters.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PJP, LABU, XPH, and BBH Company Descriptions

VanEck Biotech ETF NASDAQ:BBH

$229.64 +1.00 (+0.44%)

Closing price 09/11/2026 03:54 PM Eastern

Extended Trading

$229.32 -0.33 (-0.14%)

As of 09/11/2026 07:30 PM Eastern

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

Direxion Daily S&P Biotech Bull 3X ETF NYSEARCA:LABU

$261.30 -4.70 (-1.77%)

Closing price 09/11/2026 04:10 PM Eastern

Extended Trading

$262.25 +0.95 (+0.36%)

As of 09/11/2026 07:58 PM Eastern

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Invesco Pharmaceuticals ETF NYSEARCA:PJP

$124.09 -0.65 (-0.52%)

Closing price 09/11/2026 04:10 PM Eastern

Extended Trading

$124.11 +0.02 (+0.02%)

As of 09/11/2026 07:30 PM Eastern

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH

$67.51 -0.50 (-0.74%)

Closing price 09/11/2026 04:10 PM Eastern

Extended Trading

$67.67 +0.16 (+0.24%)

As of 09/11/2026 07:30 PM Eastern

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Compare Profitability & Earnings

Compare Dividends

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PJP, LABU, XPH, and BBH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PJP, LABU, XPH, and BBH Company Descriptions

VanEck Biotech ETF NASDAQ:BBH

Direxion Daily S&P Biotech Bull 3X ETF NYSEARCA:LABU

Invesco Pharmaceuticals ETF NYSEARCA:PJP

SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Compare Profitability & Earnings

Compare Dividends

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PJP, LABU, XPH, and BBH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PJP, LABU, XPH, and BBH Company Descriptions

VanEck Biotech ETF NASDAQ:BBH

Direxion Daily S&P Biotech Bull 3X ETF NYSEARCA:LABU

Invesco Pharmaceuticals ETF NYSEARCA:PJP

SPDR S&P Pharmaceuticals ETF NYSEARCA:XPH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools